Search - tctmd.com

Displaying 881 - 900 of 1055

Sort: Relevancy | Date

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Presentation TCT Mediterranean 2012

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Presenter: C. Moretti

May 04, 2012

Presentation TCT Mediterranean 2012

Bioabsorbable Stents and Polymers: Is It Prime Time?

Presenter: Eugenia Nikolsky

May 04, 2012

Presentation TCT Russia 2012

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Presenter: Gregg W. Stone

April 26, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

L.A. McKeown

April 25, 2012

Presentation Fellows 2012

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: David Kandzari

April 21, 2012

Presentation Fellows 2012

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

Presenter: Juan Granada

April 21, 2012

Presentation Fellows 2012

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Presenter: Issam Moussa

April 21, 2012

Presentation Fellows 2012

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: Gregg Stone

April 21, 2012

News Daily News

La Anemia de Base Aumenta el Riesgo de Trombosis del Stent tras la Colocación de un SLF

L.A. McKeown

April 04, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Daily News

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

Jason Kahn

April 03, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

Advertisement

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Strong Showing for Bioabsorbable-Scaffold DES

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Bioabsorbable Stents and Polymers: Is It Prime Time?

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

La Anemia de Base Aumenta el Riesgo de Trombosis del Stent tras la Colocación de un SLF

Baseline Anemia Raises Risk for Stent Thrombosis After DES

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content